Attendance Allowance for Macular Degeneration
Age-related macular degeneration (AMD) causes progressive loss of central vision while often leaving peripheral vision relatively intact — a distinctive pattern that can be confusing to others and easy to underestimate, since someone with AMD might still be able to see movement or navigate a familiar room while being unable to read, recognise faces, or see fine detail. This guide explains how Attendance Allowance assesses AMD-related care needs, and how to describe a claim that reflects the condition’s genuine impact.
What is Attendance Allowance?
Attendance Allowance is a tax-free, non-means-tested benefit for people who have reached State Pension age and need help with personal care or supervision because of a disability or health condition. It pays £76.70 a week at the lower rate, or £114.60 a week at the higher rate (2026/27 rates) — paid every four weeks, so £306.80 or £458.40 per payment.
It isn’t means-tested — income, savings, and pension have no bearing on entitlement — and it’s completely tax-free. There’s no fixed list of qualifying conditions: the assessment is based entirely on the actual care and supervision needed, whatever the severity of your AMD.
The distinctive pattern of central vision loss
AMD specifically affects the macula, the part of the retina responsible for sharp, detailed central vision. This creates a pattern that’s different from many other forms of sight loss:
- Central vision — often significantly affected, making reading, recognising faces, seeing fine detail, and tasks requiring precise focus very difficult
- Peripheral vision — often relatively preserved, meaning someone with AMD can sometimes still navigate familiar spaces, detect movement, and get around reasonably well in terms of general mobility
This pattern can be confusing to others, including sometimes assessors, since someone with significant AMD might appear to “see fine” in terms of general awareness while genuinely being unable to read a letter, recognise a friend’s face across a room, or thread a needle. It’s worth explaining this distinction clearly on a claim, since central and peripheral vision loss affect very different activities.
Wet and dry AMD
There are two main types of AMD, and it’s worth being clear about which applies to you:
- Dry AMD — the more common type, involving gradual thinning of the macula over time, with vision loss typically progressing slowly
- Wet AMD — involves abnormal blood vessel growth under the retina, and can cause more rapid vision loss if untreated, but is often managed with regular injection treatment that can slow or halt progression
The burden of regular eye injections
Many people with wet AMD receive regular injections into the eye (anti-VEGF treatment) to slow progression, sometimes as often as monthly, particularly in the early stages of treatment. This creates a significant ongoing burden that’s easy to overlook in a claim:
- Frequent hospital or clinic appointments, often requiring someone to accompany you, particularly since vision is often temporarily affected immediately after the injection
- The cumulative time and disruption of ongoing, indefinite treatment, sometimes over years
- Anxiety or distress associated with repeated eye injections, which many people find genuinely difficult
- Difficulty travelling to and from appointments independently, particularly if driving is no longer safe
If you receive ongoing injection treatment, it’s worth describing this burden specifically, including how often you attend, whether you need someone to accompany or collect you, and the impact on your daily routine.
Activities where macular degeneration commonly affects daily living
- Reading and understanding signs, symbols, and words — this is usually one of the most significantly affected activities, since central vision loss directly impairs the ability to read text of any size without significant magnification or assistance
- Preparing food — reading labels, judging whether food is cooked, and precise tasks like chopping can all be affected by loss of central vision
- Recognising people — difficulty recognising faces, even of close family members, particularly from a distance, which can affect social engagement and cause distress
- Managing therapy or monitoring a health condition — reading medication labels and dosages, and managing frequent treatment appointments, both require support
- Planning and following journeys — while peripheral vision may help with general navigation, reading signs, timetables, or unfamiliar written information can still be a significant barrier
How the day/night test applies
Attendance Allowance has two rates, based on when help is needed:
- Lower rate — help or supervision is needed frequently during the day, or prolonged/repeated supervision is needed at night, but not both
- Higher rate — help is needed both during the day and at night, or Special Rules for terminal illness apply
For AMD, daytime needs are usually the most significant — reading, medication management, appointment attendance, and general daily tasks requiring central vision. Nighttime needs can include difficulty adjusting to low light (which can be worse with AMD) affecting safe movement around the home after dark, or needing help with anything requiring vision during the night.
Worked example: describing needs clearly
Weak: “I have macular degeneration and it affects my eyesight.”
Stronger: “I can walk around my house without bumping into things because my side vision is still okay, but I can’t read anything — not even large print — without a strong magnifier, and even then it takes me much longer. I can’t recognise my grandchildren’s faces unless they’re very close or speak to me first. I go to the hospital for eye injections every six weeks, and my daughter has to drive me because my vision is blurred for the rest of the day afterwards. I’ve also started missing details when cooking — I burned food twice last month because I couldn’t see it was overdone until it was too late.”
The second version gives a decision-maker a clear picture of the central/peripheral vision distinction, ongoing treatment burden, and specific safety and functional consequences — far more useful than a general statement about “eyesight problems.”
AMD and mood
Vision loss, particularly affecting activities people have valued for a lifetime like reading or recognising loved ones’ faces, can understandably have a significant emotional impact, including low mood or social withdrawal. While Attendance Allowance is assessed on functional care needs rather than emotional wellbeing directly, if low mood affects your motivation to engage with tasks, appointments, or social situations, this context can be worth mentioning alongside the practical, functional difficulties described elsewhere in your claim.
If you live alone
You don’t need someone currently helping you to qualify — the test is whether you need help or supervision, whether or not it’s currently in place. Many people living alone with AMD manage by adapting routines significantly, sometimes without adequate support in place for tasks like reading post, managing medication, or attending appointments safely. If this applies to you, describe honestly what help would make a genuine difference, and any risks or difficulties this creates.
Evidence that helps
- An ophthalmologist or optometrist letter confirming your AMD diagnosis, type (wet or dry), and visual function
- Details of any ongoing injection treatment, including frequency and how it affects you afterwards
- Confirmation of your Certificate of Vision Impairment (CVI) or sight loss registration, if you have one, though this isn’t required for a strong claim
- A completed symptom diary — useful for capturing specific situations where central vision loss caused difficulty or safety concerns
- A statement from a family member or carer describing what they observe and the support they provide, particularly around appointments and reading tasks
Common mistakes
- Not explaining the central/peripheral vision distinction. Being able to move around reasonably well doesn’t mean central vision tasks like reading or recognising faces are unaffected — describe both separately.
- Underplaying the burden of ongoing treatment. Regular eye injections and appointments are a genuine, ongoing part of managing AMD and should be described as part of your overall care needs.
- Assuming magnifiers or aids fully resolve reading difficulties. If tasks still take much longer or remain difficult even with aids, this remains relevant to your claim.
- Not mentioning safety incidents. Difficulty judging distances, missing visual cues while cooking, or other safety-related consequences of central vision loss are directly relevant.
How Attendance Allowance interacts with other support
A successful claim can also increase entitlement to Pension Credit (via the Severe Disability Addition), Housing Benefit, and Council Tax Reduction. Let whichever office administers these know once the Attendance Allowance award is confirmed, since increases aren’t always applied automatically.
Reviews and renewals
Most Attendance Allowance awards don’t have a fixed end date, though circumstances can be reviewed, and any significant change in needs should be reported. Since AMD, particularly the dry form, can progress over time, ask for a review if your vision deteriorates further or treatment requirements change.
Frequently asked questions
Does macular degeneration only affect reading, or does it affect other things too? It primarily affects central vision, which impacts reading, recognising faces, and fine detail tasks, but can also affect food preparation, medication management, and other daily activities requiring precise vision.
I can still get around my house fine — does that mean I won’t qualify? Not necessarily — peripheral vision often remains relatively intact with AMD, but this doesn’t mean central vision tasks like reading or recognising people are unaffected. Describe both aspects separately.
Does having regular eye injections count towards my care needs? Yes — the frequency of appointments, need for someone to accompany you, and impact on your day (including temporary vision effects afterwards) are all relevant to describe.
What’s the difference between wet and dry AMD for my claim? The assessment is based on your actual functional impact rather than the specific type, but wet AMD often involves the additional burden of ongoing injection treatment, which is worth describing if it applies to you.
Will claiming Attendance Allowance affect my other benefits? No — it’s tax-free, doesn’t count as income for means-tested benefits, and can increase entitlement to Pension Credit, Housing Benefit, and Council Tax Reduction.
What organisations can help with a macular degeneration claim? The Macular Society and RNIB both provide information and support specific to living with AMD and sight loss, in addition to general welfare rights services like Citizens Advice.
What happens if my claim is refused? You can request a Mandatory Reconsideration, and if that doesn’t change the outcome, appeal to an independent tribunal. See our guide to appealing a benefit decision for the full process.
Do I need to be registered as sight impaired to claim? No — registration isn’t required. The assessment is based on your actual functional impact, regardless of whether you’re formally registered.
Sources
Content reviewed for accuracy against 2026/27 DWP rates. Last reviewed: 31 July 2026